January 4, 2018 / 5:18 PM / 18 days ago

BRIEF-Adocia Announces Expanded Biochaperone Product Portfolio Beyond Diabetes

Jan 4 (Reuters) - ADOCIA SA:

* ADOCIA ANNOUNCES EXPANDED BIOCHAPERONE® PRODUCT PORTFOLIO BEYOND DIABETES

* BIOCHAPERONE TO BE DEPLOYED IN SELECTED RANGE OF INJECTABLE THERAPEUTICS ACROSS NUMEROUS THERAPEUTIC AREAS​

* ‍INITIAL PROGRAMS ADDED INCLUDE READY-TO-INJECT VERSION OF TEDUGLUTIDE FOR TREATMENT OF SHORT BOWEL SYNDROME​

* ‍INITIAL PROGRAMS ADDED INCLUDE FIXED DOSE COMBINATION OF GLUCAGON AND EXENATIDE FOR TREATMENT OF OBESITY​

* ‍EXPANSION OF PORTFOLIO CREATES NEW PARTNERSHIP OPPORTUNITIES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below